- Home
- DHI vs ZTS Comparison
DHI vs ZTS Comparison
Compare DHI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHI | ZTS |
|---|---|---|
| Founded | 1978 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 48.7B |
| IPO Year | 1995 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DHI | ZTS |
|---|---|---|
| Price | $141.58 | $118.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $157.92 | $156.20 |
| AVG Volume (30 Days) | 2.5M | ★ 3.2M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | 1.29% | ★ 1.80% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | 2.03 | ★ 6.02 |
| Revenue | ★ $34,250,400,000.00 | $9,467,000,000.00 |
| Revenue This Year | $0.44 | $5.67 |
| Revenue Next Year | $5.89 | $4.85 |
| P/E Ratio | $68.81 | ★ $19.58 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $110.44 | $113.30 |
| 52 Week High | $183.62 | $172.23 |
Technical Indicators
Market Signals| Indicator | DHI | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 47.27 |
| Support Level | $140.69 | $115.35 |
| Resistance Level | $141.82 | $130.52 |
| Average True Range (ATR) | 4.28 | 3.02 |
| MACD | 0.93 | 0.47 |
| Stochastic Oscillator | 83.05 | 53.15 |
Price Performance
Historical ComparisonAbout DHI D.R. Horton Inc.
With operations in 126 markets across 36 states, D.R. Horton is the leading homebuilder in the United States. It mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.